London
· Delayed Price · Currency is GBP · Price in USD Accelerate Diagnostics Statistics
Total Valuation
Accelerate Diagnostics has a market cap or net worth of GBP 27.20 million. The enterprise value is 57.82 million.
| Market Cap | 27.20M |
| Enterprise Value | 57.82M |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +83.18% |
| Shares Change (QoQ) | +8.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 12.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.45 |
| EV / Sales | 6.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.82 |
Financial Position
The company has a current ratio of 1.50
| Current Ratio | 1.50 |
| Quick Ratio | 1.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.14 |
| Interest Coverage | -3.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -66.49% |
| Return on Invested Capital (ROIC) | -395.97% |
| Return on Capital Employed (ROCE) | -271.10% |
| Revenue Per Employee | 66,308 |
| Profits Per Employee | -297,627 |
| Employee Count | 134 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.20% in the last 52 weeks. The beta is 0.60, so Accelerate Diagnostics's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -4.20% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 7.27 |
| Relative Strength Index (RSI) | 49.66 |
| Average Volume (20 Days) | 502 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.37 |
Income Statement
In the last 12 months, Accelerate Diagnostics had revenue of GBP 8.89 million and -39.88 million in losses. Loss per share was -1.93.
| Revenue | 8.89M |
| Gross Profit | 2.15M |
| Operating Income | -28.43M |
| Pretax Income | -39.46M |
| Net Income | -39.88M |
| EBITDA | -25.87M |
| EBIT | -28.43M |
| Loss Per Share | -1.93 |
Balance Sheet
The company has 15.60 million in cash and 44.00 million in debt, giving a net cash position of -28.40 million.
| Cash & Cash Equivalents | 15.60M |
| Total Debt | 44.00M |
| Net Cash | -28.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -36.17M |
| Book Value Per Share | -1.45 |
| Working Capital | 6.85M |
Cash Flow
In the last 12 months, operating cash flow was -20.06 million and capital expenditures -461,836, giving a free cash flow of -20.52 million.
| Operating Cash Flow | -20.06M |
| Capital Expenditures | -461,836 |
| Free Cash Flow | -20.52M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 24.25% |
| Operating Margin | -319.99% |
| Pretax Margin | -444.12% |
| Profit Margin | n/a |
| EBITDA Margin | -291.17% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Accelerate Diagnostics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -83.18% |
| Shareholder Yield | -83.18% |
| Earnings Yield | -146.63% |
| FCF Yield | -75.43% |
Stock Splits
The last stock split was on July 12, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Accelerate Diagnostics has an Altman Z-Score of -33.61. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -33.61 |
| Piotroski F-Score | n/a |